NO328021B1 - Analysemetode for fosfatase-malsokende toksiner, samt sett og anvendelse derav - Google Patents
Analysemetode for fosfatase-malsokende toksiner, samt sett og anvendelse derav Download PDFInfo
- Publication number
- NO328021B1 NO328021B1 NO20012304A NO20012304A NO328021B1 NO 328021 B1 NO328021 B1 NO 328021B1 NO 20012304 A NO20012304 A NO 20012304A NO 20012304 A NO20012304 A NO 20012304A NO 328021 B1 NO328021 B1 NO 328021B1
- Authority
- NO
- Norway
- Prior art keywords
- ligand
- phosphatase
- toxin
- binding
- targeting
- Prior art date
Links
- 231100000765 toxin Toxicity 0.000 title claims abstract description 158
- 239000003053 toxin Substances 0.000 title claims abstract description 158
- 108700012359 toxins Proteins 0.000 title claims abstract description 158
- 238000004458 analytical method Methods 0.000 title claims description 35
- 239000003446 ligand Substances 0.000 claims abstract description 165
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims abstract description 57
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims abstract description 50
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims abstract description 24
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims abstract description 24
- 239000007787 solid Substances 0.000 claims abstract description 16
- 230000008685 targeting Effects 0.000 claims abstract description 8
- 239000007864 aqueous solution Substances 0.000 claims abstract description 6
- 238000003556 assay Methods 0.000 claims abstract description 6
- 230000027455 binding Effects 0.000 claims description 55
- 108010073357 cyanoginosin LR Proteins 0.000 claims description 26
- 235000015170 shellfish Nutrition 0.000 claims description 23
- 102000006478 Protein Phosphatase 2 Human genes 0.000 claims description 20
- 108010058956 Protein Phosphatase 2 Proteins 0.000 claims description 20
- 241000192700 Cyanobacteria Species 0.000 claims description 17
- OWHASZQTEFAUJC-UHFFFAOYSA-N MCYR Natural products COC(Cc1ccccc1)C(C)C=C(/C)C=CC2NC(=O)C(CCCNC(=N)N)NC(=O)C(C)C(NC(=O)C(Cc3ccc(O)cc3)NC(=O)C(C)NC(=O)C(=C)N(C)C(=O)CCC(NC(=O)C2C)C(=O)O)C(=O)O OWHASZQTEFAUJC-UHFFFAOYSA-N 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- OWHASZQTEFAUJC-GJRPNUFSSA-N (5r,8s,11r,12s,15s,18s,19s,22r)-15-[3-(diaminomethylideneamino)propyl]-8-[(4-hydroxyphenyl)methyl]-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazac Chemical compound C([C@H](OC)[C@@H](C)\C=C(/C)\C=C\[C@H]1[C@@H](C(=O)N[C@H](CCC(=O)N(C)C(=C)C(=O)N[C@H](C)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@H]([C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1)C(O)=O)C(O)=O)C)C1=CC=CC=C1 OWHASZQTEFAUJC-GJRPNUFSSA-N 0.000 claims description 16
- 108010080307 microcystin YR Proteins 0.000 claims description 16
- OWHASZQTEFAUJC-BKBILFGQSA-N microcystin-YR Natural products CO[C@@H](Cc1ccccc1)[C@@H](C)C=C(C)C=C[C@@H]2NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](C)[C@@H](NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](C)NC(=O)C(=C)N(C)C(=O)CC[C@@H](NC(=O)[C@H]2C)C(=O)O)C(=O)O OWHASZQTEFAUJC-BKBILFGQSA-N 0.000 claims description 16
- 241000195493 Cryptophyta Species 0.000 claims description 14
- 239000007790 solid phase Substances 0.000 claims description 13
- QNDVLZJODHBUFM-WFXQOWMNSA-N okadaic acid Chemical compound C([C@H](O1)[C@H](C)/C=C/[C@H]2CC[C@@]3(CC[C@H]4O[C@@H](C([C@@H](O)[C@@H]4O3)=C)[C@@H](O)C[C@H](C)[C@@H]3[C@@H](CC[C@@]4(OCCCC4)O3)C)O2)C(C)=C[C@]21O[C@H](C[C@@](C)(O)C(O)=O)CC[C@H]2O QNDVLZJODHBUFM-WFXQOWMNSA-N 0.000 claims description 12
- VEFJHAYOIAAXEU-UHFFFAOYSA-N okadaic acid Natural products CC(CC(O)C1OC2CCC3(CCC(O3)C=CC(C)C4CC(=CC5(OC(CC(C)(O)C(=O)O)CCC5O)O4)C)OC2C(O)C1C)C6OC7(CCCCO7)CCC6C VEFJHAYOIAAXEU-UHFFFAOYSA-N 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- ZYZCGGRZINLQBL-GWRQVWKTSA-N microcystin-LR Chemical compound C([C@H](OC)[C@@H](C)\C=C(/C)\C=C\[C@H]1[C@@H](C(=O)N[C@H](CCC(=O)N(C)C(=C)C(=O)N[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]([C@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(O)=O)C(O)=O)C)C1=CC=CC=C1 ZYZCGGRZINLQBL-GWRQVWKTSA-N 0.000 claims description 10
- DIDLWIPCWUSYPF-UHFFFAOYSA-N microcystin-LR Natural products COC(Cc1ccccc1)C(C)C=C(/C)C=CC2NC(=O)C(NC(CCCNC(=N)N)C(=O)O)NC(=O)C(C)C(NC(=O)C(NC(CC(C)C)C(=O)O)NC(=O)C(C)NC(=O)C(=C)N(C)C(=O)CCC(NC(=O)C2C)C(=O)O)C(=O)O DIDLWIPCWUSYPF-UHFFFAOYSA-N 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 230000024033 toxin binding Effects 0.000 claims description 10
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 8
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 8
- IXBQSRWSVIBXNC-HSKGSTCASA-N Nodularin Chemical compound C([C@H](OC)[C@@H](C)\C=C(/C)\C=C\[C@H]1[C@@H](C(=O)N[C@H](CCC(=O)N(C)C(=C\C)/C(=O)N[C@H]([C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1)C(O)=O)C(O)=O)C)C1=CC=CC=C1 IXBQSRWSVIBXNC-HSKGSTCASA-N 0.000 claims description 8
- IXBQSRWSVIBXNC-UHFFFAOYSA-N Nodularin Natural products N1C(=O)C(CCCN=C(N)N)NC(=O)C(C)C(C(O)=O)NC(=O)C(=CC)N(C)C(=O)CCC(C(O)=O)NC(=O)C(C)C1C=CC(C)=CC(C)C(OC)CC1=CC=CC=C1 IXBQSRWSVIBXNC-UHFFFAOYSA-N 0.000 claims description 8
- 108010065793 nodularin Proteins 0.000 claims description 8
- 231100000784 hepatotoxin Toxicity 0.000 claims description 6
- 230000002401 inhibitory effect Effects 0.000 claims description 6
- 239000004005 microsphere Substances 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 3
- 230000002860 competitive effect Effects 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 29
- 238000000034 method Methods 0.000 description 16
- 239000011324 bead Substances 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 241000199914 Dinophyceae Species 0.000 description 7
- 108010058683 Immobilized Proteins Proteins 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 230000009137 competitive binding Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000003345 scintillation counting Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- SRUWWOSWHXIIIA-UKPGNTDSSA-N Cyanoginosin Chemical compound N1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](C)[C@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C(=C)N(C)C(=O)CC[C@H](C(O)=O)N(C)C(=O)[C@@H](C)[C@@H]1\C=C\C(\C)=C\[C@H](C)[C@@H](O)CC1=CC=CC=C1 SRUWWOSWHXIIIA-UKPGNTDSSA-N 0.000 description 4
- 241000237536 Mytilus edulis Species 0.000 description 4
- 208000005374 Poisoning Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 108010067094 microcystin Proteins 0.000 description 4
- 235000020638 mussel Nutrition 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 230000009870 specific binding Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 241000218612 Dinophysis Species 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- -1 Haugland Substances 0.000 description 3
- 241000059630 Nodularia <Cyanobacteria> Species 0.000 description 3
- 102000015636 Oligopeptides Human genes 0.000 description 3
- 108010038807 Oligopeptides Proteins 0.000 description 3
- 241000237502 Ostreidae Species 0.000 description 3
- 230000006287 biotinylation Effects 0.000 description 3
- 238000007413 biotinylation Methods 0.000 description 3
- 235000020639 clam Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000003673 groundwater Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 235000020636 oyster Nutrition 0.000 description 3
- 238000002823 phage display Methods 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000237519 Bivalvia Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000192709 Microcystis sp. Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000237503 Pectinidae Species 0.000 description 2
- 241000571822 Prorocentrum sp. Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 208000004891 Shellfish Poisoning Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 101710162629 Trypsin inhibitor Proteins 0.000 description 2
- 229940122618 Trypsin inhibitor Drugs 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 2
- 230000000741 diarrhetic effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 238000006192 iodination reaction Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002581 neurotoxin Substances 0.000 description 2
- 231100000618 neurotoxin Toxicity 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000020637 scallop Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- 239000000717 tumor promoter Substances 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000192660 Aphanizomenon Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000192701 Microcystis Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000192520 Oscillatoria sp. Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- RFCWHQNNCOJYTR-IRCAEPKSSA-N Tautomycin Chemical compound O([C@H]([C@H](CC1)C)[C@H](C)CC[C@H](O)[C@H](C)C(=O)C[C@@H](O)[C@@H](OC)[C@H](OC(=O)C[C@@H](O)C=2C(OC(=O)C=2C)=O)C(C)C)[C@@]21CC[C@@H](C)[C@H](CC[C@H](C)C(C)=O)O2 RFCWHQNNCOJYTR-IRCAEPKSSA-N 0.000 description 1
- RFCWHQNNCOJYTR-UHFFFAOYSA-N Tautomycin Natural products CC=1C(=O)OC(=O)C=1C(O)CC(=O)OC(C(C)C)C(OC)C(O)CC(=O)C(C)C(O)CCC(C)C(C(CC1)C)OC21CCC(C)C(CCC(C)C(C)=O)O2 RFCWHQNNCOJYTR-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- FKAWLXNLHHIHLA-YCBIHMBMSA-N [(2r,3r,5r,7r,8s,9s)-2-[(1s,3s,4s,5r,6r,7e,9e,11e,13z)-14-cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyltetradeca-7,9,11,13-tetraenyl]-9-[(e)-3-[2-[(2s)-4-[[(2s,3s,4s)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanoyl]amino]butan-2-yl]-1,3-oxazol-4 Chemical compound O1C([C@@H](C)CCNC(=O)[C@@H](O)[C@@H](O)[C@H](COC)N(C)C)=NC(\C=C\C[C@H]2[C@H]([C@H](O)C[C@]3(O2)C([C@@H](OP(O)(O)=O)[C@@H]([C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C(\C)=C\C=C\C(\C)=C/C#N)OC)O3)(C)C)C)=C1 FKAWLXNLHHIHLA-YCBIHMBMSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000003948 anatoxin Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000003653 coastal water Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000010807 negative regulation of binding Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9824772.9A GB9824772D0 (en) | 1998-11-11 | 1998-11-11 | Assay |
| PCT/GB1999/003756 WO2000028325A1 (en) | 1998-11-11 | 1999-11-11 | Assay for phosphatase-targeting toxins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20012304D0 NO20012304D0 (no) | 2001-05-10 |
| NO20012304L NO20012304L (no) | 2001-06-28 |
| NO328021B1 true NO328021B1 (no) | 2009-11-09 |
Family
ID=10842302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012304A NO328021B1 (no) | 1998-11-11 | 2001-05-10 | Analysemetode for fosfatase-malsokende toksiner, samt sett og anvendelse derav |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1129352B1 (ru) |
| JP (1) | JP4460779B2 (ru) |
| KR (1) | KR100674517B1 (ru) |
| CN (1) | CN1249435C (ru) |
| AT (1) | ATE288588T1 (ru) |
| AU (1) | AU769203B2 (ru) |
| BR (1) | BR9915299A (ru) |
| CA (1) | CA2349942A1 (ru) |
| CZ (1) | CZ20011673A3 (ru) |
| DE (1) | DE69923581T2 (ru) |
| DK (1) | DK1129352T3 (ru) |
| EA (1) | EA002710B1 (ru) |
| ES (1) | ES2237953T3 (ru) |
| GB (1) | GB9824772D0 (ru) |
| HK (1) | HK1040546B (ru) |
| HU (1) | HUP0104194A2 (ru) |
| ID (1) | ID30236A (ru) |
| IL (2) | IL143047A0 (ru) |
| NO (1) | NO328021B1 (ru) |
| NZ (1) | NZ511757A (ru) |
| PL (1) | PL198749B1 (ru) |
| WO (1) | WO2000028325A1 (ru) |
| ZA (1) | ZA200103796B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100381718B1 (ko) * | 2000-06-26 | 2003-04-26 | 한국생명공학연구원 | 프로테인 포스파테이스를 이용한 마이크로시스틴의비색정량법 |
| JP2003079365A (ja) * | 2001-09-07 | 2003-03-18 | Kanegafuchi Chem Ind Co Ltd | 環境有害化学物質の高感度検出法 |
| JP6755952B2 (ja) * | 2016-09-14 | 2020-09-16 | レボテック カンパニー，リミティド | 人工組織前駆体及びそれを調製する方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1302920C (en) * | 1987-10-09 | 1992-06-09 | Taizo Uda | Monoclonal antibody to okadaic acids, process for producing the monoclonal antibody, assay reagent for assaying okadaic acids using the monoclonal antibody, and assay method |
| US5180665A (en) * | 1990-11-21 | 1993-01-19 | Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada | Method for quantitatively assaying the presence of diarrhetic shellfish poisoning toxins in marine samples |
| CA2093521C (en) * | 1991-08-09 | 2000-02-22 | Shiro Matsuura | Detection of diarrheogenic shellfish toxins |
| US5525525A (en) * | 1994-05-11 | 1996-06-11 | Asian Pacific Research Foundation | Immuno-latex chromatographic procedure for detection of ciguatoxin, and related polyether marine toxins |
-
1998
- 1998-11-11 GB GBGB9824772.9A patent/GB9824772D0/en not_active Ceased
-
1999
- 1999-11-11 IL IL14304799A patent/IL143047A0/xx active IP Right Grant
- 1999-11-11 BR BR9915299-1A patent/BR9915299A/pt not_active IP Right Cessation
- 1999-11-11 DK DK99954218T patent/DK1129352T3/da active
- 1999-11-11 ID IDW00200101252A patent/ID30236A/id unknown
- 1999-11-11 PL PL347632A patent/PL198749B1/pl unknown
- 1999-11-11 EA EA200100452A patent/EA002710B1/ru not_active IP Right Cessation
- 1999-11-11 JP JP2000581452A patent/JP4460779B2/ja not_active Expired - Fee Related
- 1999-11-11 CA CA002349942A patent/CA2349942A1/en not_active Abandoned
- 1999-11-11 NZ NZ511757A patent/NZ511757A/en not_active IP Right Cessation
- 1999-11-11 ES ES99954218T patent/ES2237953T3/es not_active Expired - Lifetime
- 1999-11-11 WO PCT/GB1999/003756 patent/WO2000028325A1/en not_active Application Discontinuation
- 1999-11-11 HU HU0104194A patent/HUP0104194A2/hu unknown
- 1999-11-11 CN CNB998145688A patent/CN1249435C/zh not_active Expired - Fee Related
- 1999-11-11 KR KR1020017005894A patent/KR100674517B1/ko not_active IP Right Cessation
- 1999-11-11 AU AU10635/00A patent/AU769203B2/en not_active Ceased
- 1999-11-11 AT AT99954218T patent/ATE288588T1/de not_active IP Right Cessation
- 1999-11-11 CZ CZ20011673A patent/CZ20011673A3/cs unknown
- 1999-11-11 DE DE69923581T patent/DE69923581T2/de not_active Expired - Lifetime
- 1999-11-11 EP EP99954218A patent/EP1129352B1/en not_active Expired - Lifetime
-
2001
- 2001-05-08 IL IL143047A patent/IL143047A/en not_active IP Right Cessation
- 2001-05-10 NO NO20012304A patent/NO328021B1/no not_active IP Right Cessation
- 2001-05-10 ZA ZA200103796A patent/ZA200103796B/en unknown
-
2002
- 2002-02-23 HK HK02101402.8A patent/HK1040546B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2349942A1 (en) | 2000-05-18 |
| GB9824772D0 (en) | 1999-01-06 |
| ES2237953T3 (es) | 2005-08-01 |
| HK1040546A1 (en) | 2002-06-14 |
| DE69923581T2 (de) | 2005-12-29 |
| ZA200103796B (en) | 2001-11-22 |
| NO20012304D0 (no) | 2001-05-10 |
| HUP0104194A2 (hu) | 2002-03-28 |
| NO20012304L (no) | 2001-06-28 |
| KR20010092728A (ko) | 2001-10-26 |
| PL347632A1 (en) | 2002-04-22 |
| JP4460779B2 (ja) | 2010-05-12 |
| KR100674517B1 (ko) | 2007-01-26 |
| WO2000028325A1 (en) | 2000-05-18 |
| ID30236A (id) | 2001-11-15 |
| IL143047A0 (en) | 2002-04-21 |
| PL198749B1 (pl) | 2008-07-31 |
| CZ20011673A3 (cs) | 2001-11-14 |
| BR9915299A (pt) | 2001-08-07 |
| CN1338051A (zh) | 2002-02-27 |
| CN1249435C (zh) | 2006-04-05 |
| DK1129352T3 (da) | 2005-06-06 |
| AU1063500A (en) | 2000-05-29 |
| AU769203B2 (en) | 2004-01-22 |
| NZ511757A (en) | 2003-10-31 |
| JP2002529738A (ja) | 2002-09-10 |
| HK1040546B (zh) | 2005-06-24 |
| DE69923581D1 (de) | 2005-03-10 |
| EA200100452A1 (ru) | 2002-02-28 |
| EP1129352A1 (en) | 2001-09-05 |
| ATE288588T1 (de) | 2005-02-15 |
| EA002710B1 (ru) | 2002-08-29 |
| IL143047A (en) | 2007-07-04 |
| EP1129352B1 (en) | 2005-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bouaıcha et al. | A colorimetric and fluorometric microplate assay for the detection of microcystin-LR in drinking water without preconcentration | |
| Wells et al. | Microscale testing in aquatic toxicology: advances, techniques, and practice | |
| Pazos et al. | Resonant mirror biosensor detection method based on yessotoxin–phosphodiesterase interactions | |
| Li et al. | Quick detection method for paralytic shellfish toxins (PSTs) monitoring in freshwater-A review | |
| JP2004524516A (ja) | 麻痺性貝毒のアッセイ | |
| CN110426515B (zh) | 一种时间分辨荧光免疫层析技术检测污水中痕量毒品的试剂盒及其应用 | |
| Liu et al. | Triple functional small-molecule-protein conjugate mediated optical biosensor for quantification of estrogenic activities in water samples | |
| US6127136A (en) | Detection of dioxin-like compounds by detection of transformed Ah receptor/ARNT complex | |
| NO328021B1 (no) | Analysemetode for fosfatase-malsokende toksiner, samt sett og anvendelse derav | |
| AU2007200433B2 (en) | Biomolecular toxicity assay | |
| Yue et al. | Toxicity evaluation of MC-LR in different fish organs based on aptamer-recognized SERS tag coupled with magnetic separation | |
| MXPA01004700A (en) | Assay for phosphatase-targeting toxins | |
| Aslam et al. | A Review on Validation of Enzyme Linked Immunosorbent Assay (Elisa) Techniques for Detection and Quantification of Different Contaminant in Aquatic Environment | |
| US5250413A (en) | Sublethal bioassay for environmental quality | |
| CN103675286A (zh) | 一种林可霉素化学发光酶联免疫快速检测试剂盒 | |
| JP2002529738A5 (ru) | ||
| AU2002220374B2 (en) | Assay for paralytic shellfish toxin | |
| Palleschi et al. | Rapid detection of seafood toxins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |